Association of periorbital melanosis with pigmentary demarcation line-F
Keywords:
Periorbital melanosis, pigmentary demarcation lines, Wood’s lamp examinationAbstract
Objective To determine the association of periorbital melanosis with pigmentary demarcation line-F. Methods This observational study was carried out at the Department of Dermatology, Services Institute of Medical Sciences/ Services Hospital Lahore, from January 2017 to June 2017. A total of 50 patients of periorbital melanosis of any age and either sex were included. The association between periorbital melanosis (POM) and pigmentary demarcation line-F (PDL-F), if present, was determined by close inspection of the patients, histopathological and Wood’s lamp examination. Results In 44 (88%) patients, PDL-F was observed along with POM. Histopathological examination carried out on 5 patients showed melanin pigment within dermal macrophages in both POM and PDL-F. In 9 (18%) patients, both POM and PDL-F became indiscernible on Wood’s lamp examination. Conclusion POM and PDL-F are common chronic and same pigmentary conditions and should be considered as a single entity.References
Sarkar R. Idiopathic cutaneous hyperchromia at the orbital region of periorbital hyperpigmentation. J Cutan Aesthet Surg. 2012;5:183-4.
Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital hyperpigmentation: a comprehensive review. J Clin Aesthet Dermatol. 2016;9:49-55.
Huang YL, Chang SL, Ma L, Lee Mc, Hu S. Clinical analysis and classification of dark eye circle. Int J Dermatol. 2014;53:164-70.
Malakar S, Lahiri K, Banerjee U, Mondal S, Sarangi S. Periorbital melanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol. 2007;73:323-5.
Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH et al. A randomized control trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159:697-703.
Momosawa A, Kurita M, Ozaki M, Miyamoto S, Kobayashi Y, Ban I et al. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. Plast Reconstr Surg. 2008;121:282-8.
Gracia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22:443-7.
Somani VK, Razvi F, Sita VV. Pigmentary demarcation lines over the face. Indian J Dermatol Venereol Leprol. 2004;70:336-41.
Krive JM. How common is pigmentary mosaicism? 1997;133:527-8.
Maleville J, Taoeb A. Pigmentary demarcation lines as markers of neural development. Arch Dermatol. 1997;133:1459.
Singh N, Thappa DM. Pigmentary demarcation lines. Pigment Int. 2014;1(1):13-6.
Al-Samary A, Al-Mohizea S, Bin-Saif G, Al-Balbeesi A. Pigmentary demarcation lines on the face in Saudi women. Indian J Dermatol Venereol Leprol. 2010;76:378-81.
Sheth PB, Shah HA, Dave JN. Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders. Indian J Dermatol. 2014;59:151-7.
Goodman RM, Belcher RW. Periorbital hyperpigmentation. An overlooked genetic disorder of pigmentation. Arch Dermatol. 1969;100:169-74.
Ranu H, Thung S, Goh BK, Burger A, Goh CL. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg. 2011;37:1297-303.
Watanabe S, Nakai K, Ohnishi T. Condition known as “dark rings under the eyes” in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg. 2006;32:785-9.
